New datasets | 1. Expiration date for observational studies and trials conducted before year 2010 |
Actionable criteria | 2. Definition should be based on actionable and modifiable criteria, including VD/VT, lung imaging, biomarker levels, etc. |
PaO2/FiO2 | 3. It should be assessed under standardized conditions (e.g., measured at predefined FiO2 and PEEP levels) |
4. Categorization may include the threshold of 150 mmHg (< 150, ≥ 150) | |
Measures of severity | Two measures of “true” severity of ARDS: |
5. Lung injury per se: “Severe” ARDS should not be based only on PaO2/FiO2 | |
6. Severity of patient illness, including comorbidities and frailty | |
Enrichment strategies | 7. Prediction or prognostic enrichment strategies for inclusion of patients into therapeutic clinical trials. The use of artificial intelligence techniques may help |
Pulmonary circulation | 8. More precise information about the anatomic/physiologic state of the pulmonary vascular circulation |
Stratification, classification, or sub-phenotyping | 9. An updated definition requires a new categorization or classification of severity based on gas-exchange, lung imaging, VD/VT, biomarker levels, use of non-invasive mechanical ventilation, degree of vascular permeability |
Broadening definition | 10. Excessive broadening of criteria required to diagnose ARDS should be avoided |
International professional societies | 11. Recommendations for management and treatment in the new updated ARDS definition should be implemented by International Professional Societies |
Implementation | 12. Implementation of a “Surviving ARDS (including patients at risk for) Campaign” with frequent updates |